连花清瘟胶囊治疗流行性感冒疗效和安全性的系统评价

Systematic review of clinical effect and safety of lianhuaqingwen capsule in the treatment of influenza

目的:探讨连花清瘟胶囊治疗流行性感冒的临床疗效及安全性。方法:收治流行性感冒患者70例,分为两组,每组35例。观察组给予连花清瘟胶囊治疗,对照组给予强效感冒片治疗。比较两组的临床疗效、淋巴细胞的百分比及不良反应的发生情况。结果:治疗后观察组淋巴细胞百分比显著低于治疗前(P<0.05)。观察组治疗总有效率高于对照组(P<0.05)。治疗后观察组淋巴细胞百分比显著低于对照组(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:连花清瘟胶囊对流行性感冒的治疗有较好的疗效,淋巴细胞百分比显著降低,治疗的安全性较好。

Objective:To investigate the clinical effect and safety of lianhuaqingwen capsule in the treatment of influenza.Methods:70 cases of patients with influenza were divided into two groups,with 35 cases in each group.Patients in the observation groupwere given lianhuaqingwen capsule treatment,while patients in the control group were given potent cold tablets treatment.Theclinical effect,percentage of lymphocytes and adverse reaction incidence of the two groups were compared.Results:After treatment,the percentage of lymphocytes in the observation group was significantly lower than that before treatment (P<0.05).The totaleffective rate in the observation group was higher than that of the control group (P<0.05).After treatment,the percentage oflymphocytes in the observation group was significantly lower than that in the control group (P<0.05).The difference of adversereaction incidence between groups was not statistically significant(P>0.05).Conclusion:Lianhuaqingwen capsule in the treatmentof influenza had better clinical effect and the percentage of lymphocytes decreased significantly and the treatment safety wasbetter.